Toxicity Testing: The FDA Perspective

Annals of the New York Academy of SciencesVolume 919, Issue 1 p. 75-78 Toxicity Testing: The FDA Perspective JANE E. HENNEY, Corresponding Author JANE E. HENNEY Food and Drug Administration, Rockville, Maryland, USAa Address for correspondence: Jane E. Henney, Commissioner of Food and Drugs, Food and Drug Administration, 5600 Fishers Lane, Room 14-71, Rockville, MD 20857. Voice: 301-827-2410; fax: 301-443-3100.Search for more papers by this author JANE E. HENNEY, Corresponding Author JANE E. HENNEY Food and Drug Administration, Rockville, Maryland, USAa Address for correspondence: Jane E. Henney, Commissioner of Food and Drugs, Food and Drug Administration, 5600 Fishers Lane, Room 14-71, Rockville, MD 20857. Voice: 301-827-2410; fax: 301-443-3100.Search for more papers by this author First published: 25 January 2006 https://doi.org/10.1111/j.1749-6632.2000.tb06869.xCitations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume919, Issue1TOXICOLOGY FOR THE NEXT MILLENNIUMSeptember 2000Pages 75-78 RelatedInformation